A Study to Compare the Pharmacokinetic Profiles of DW224aa and DW224a
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare and explore pharmacokinetics of zabofloxacin, the
main component of DW224aa(Test drug) and DW224a(Reference drug).